We also showed that cisplatin induces the expression of HSP27 and FAO markers (i.e., CPT1A, CD36) in cisplatin-resistant ovarian cancer cells through ROS-dependent mechanisms as NAC treatment attenuates cisplatin induction of HSP27 and FAO. This evidence concerns the gene HSPB1 and ovarian carcinoma.